# NOVARTIS AG & ANR. vs NATCO PHARMA LIMITED

Court: Delhi High Court
Date: 2025-01-08
Citation: CS(COMM)-229/2019 2025:DHC:51
Petitioner: NOVARTIS AG & ANR.
Respondent: NATCO PHARMA LIMITED

[Official PDF on Delhi High Court website](https://delhihighcourt.nic.in/app/showFileJudgment/59208012025SC2292019_170654.pdf)

## Judgment text (excerpt)

$~J3 * IN THE HIGH COURT OF DELHI AT NEW DELHI CS(COMM) 229/2019 & I.A. 10756/2024 NOVARTIS AG & ANR. .....Plaintiffs Through: Mr. Hemant Singh, Mrs. Mamta Rani Jha, Mr. Siddhanta Sharma, Mr. Abhay Tandon, Advocates M:8448683746 versus NATCO PHARMA LIMITED .....Defendant Through: Mr. J. Sai Deepak, Mr. Afzal B. Khan, Mr. Samik Mukherjee, Mr. Dominic alvares adn Mr. Avinash K. Sharma, Advs. M: 7585965845 Email: del.lit@majumdarip.com CORAM: HON'BLE MS. JUSTICE MINI PUSHKARNA JUDGMENT 08.01.2025 MINI PUSHKARNA, J: I.A. 10756/2024 (Application seeking leave to file additional written statement) 1. The instant suit has been filed by the plaintiffs seeking permanent injunction restraining the infringement of plaintiff no.1‟s Indian Patent No. 276026 (IN‟026), rendition of accounts/ damages and delivery up, etc. 2. The present application has been filed under Order VIII Rule 9 of the Code of Civil Procedure, 1908 (“CPC”), by the defendant seeking leave to file additional written statement. The defendant seeks to bring on record the pleadings and grounds related to the Divisional Application, i.e. IN 26. It is the case of the defendant that the plaintiffs have suppressed documents pertain

https://niyam.ai/judgements/high-court/2025/january/novartis-ag-anr-vs-natco-pharma-limited